<DOC>
	<DOCNO>NCT00863577</DOCNO>
	<brief_summary>The primary pharmacokinetic analysis correlation AUC amidolytic anti-Xa activity</brief_summary>
	<brief_title>Pharmacokinetic Study Two Oral Bemiparin Formulations</brief_title>
	<detailed_description />
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>1 . Healthy volunteer : male female subject age 18 45 year 2 . Body weight : 6580 Kg 3 . Not meaningful abnormality physical examination clinical history 4 . Without evidence significant organic psychiatric illness 5 . Hemogram , biochemistry coagulation normal value establish reference range local hospital laboratory 6 . Vital sign ( blood pressure , heart beat rate body temperature ) EKG within normal range 7 . Healthy volunteer participate another clinical trial do past 2 month 8 . Not give blood last 4 week . 9 . Healthy male volunteer receive heparin past 10 . Healthy male volunteer accept participate study sign write informed consent 11. contraceptive method double barrel sterile surgery 1 . Previous history alcoholism , drug dependency , drug abuse habitual psychoactive drug consumption 2 . Important consumption excite drink : alcohol consumption &gt; 30 g/day ; coffee , tea , cola &gt; 5 /day 3 . Allergy , idiosyncrasy hypersensitivity medicine 4 . Healthy volunteer receive another medication past 15 day 5 . Positive serology hepatitis B , C HIV 6 . Cardiovascular , respiratory , renal , hepatic , endocrine , gastrointestinal , hematologic , psychiatric , neurological others event 7 . Mayor Surgery last 6 month 8 . Smoking &gt; 10 cigarette / day 9 . Ethanol , cannabis , cocaine , amphetamine , benzodiazepin opiate urine 10 . Healthy volunteer familiar history evident hemorrhagic episodes 11. positive fecatest comburtest 12. positive pregnant test 13 . Bemiparin contraindication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>